Carey Anders, MD, and Susan Dent, MD, discuss the role of radiotherapy in patients with HER2-positive breast cancer and brain metastases.
Plant-Based Diet/Exercise Tied to Weight Loss in HR+ Breast Cancer
Patients with hormone receptor-positive breast cancer experienced weight loss when given a plant-based diet plus exercise.
Finding a Place for Exercise Oncology in the Treatment of Breast Cancer
Neil M. Iyengar, MD, spoke about the potential impact of exercise on patient-reported outcomes in cancer and achieving work-life balance.
39 The Influence of Reconstruction Type on Outcomes in Women Undergoing Mastectomy With Immediate Reconstruction: A Nationwide Study
Managing CDK4/6 Inhibitor, ADC Toxicity in Metastatic Breast Cancer
Sarah Donahue, MPH, NP, speaks to the importance of communicating potential adverse effects associated with treatments such as CDK4/6 inhibitors to patients with breast cancer.
T-DXd Boosts PFS Vs Chemo in HR+, HER2-Low Metastatic Breast Cancer
Secondary end points such as overall survival also appear to favor T-DXd among this breast cancer population in the phase 3 DESTINY-Breast06 trial.
Inavolisib Combo Reduces Time to Subsequent Treatment in Breast Cancer
Data also show a longer median time to deterioration for patients in the inavolisib arm in phase 3 INAVO120 trial.